Article Versions Notes

Goehringer N, Peng Y, Nitzsche B, Biermann H, Pradhan R, Schobert R, Herling M, Höpfner M, Biersack B. Improved Anticancer Activities of a New Pentafluorothio-Substituted Vorinostat-Type Histone Deacetylase Inhibitor. Pharmaceuticals. 2021; 14(12):1319. https://doi.org/10.3390/ph14121319

Goehringer, Nils, Yayi Peng, Bianca Nitzsche, Hannah Biermann, Rohan Pradhan, Rainer Schobert, Marco Herling, Michael Höpfner, and Bernhard Biersack. 2021. "Improved Anticancer Activities of a New Pentafluorothio-Substituted Vorinostat-Type Histone Deacetylase Inhibitor" Pharmaceuticals 14, no. 12: 1319. https://doi.org/10.3390/ph14121319

Goehringer, N., Peng, Y., Nitzsche, B., Biermann, H., Pradhan, R., Schobert, R., Herling, M., Höpfner, M., & Biersack, B. (2021). Improved Anticancer Activities of a New Pentafluorothio-Substituted Vorinostat-Type Histone Deacetylase Inhibitor. Pharmaceuticals, 14(12), 1319. https://doi.org/10.3390/ph14121319